Anika Therapeutics, Inc. (ANIK) — DEF 14A Filings
All DEF 14A filings from Anika Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Anika Therapeutics Files Definitive Proxy Statement
— Apr 28, 2025 Risk: low
Anika Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 28, 2025, for its annual meeting on June 20, 2025. The filing outlines informat -
Anika Therapeutics Files DEF 14A for 2023 Executive Compensation
— Jun 11, 2024 Risk: medium
Anika Therapeutics, Inc. filed a DEF 14A on June 11, 2024, for the fiscal year ending December 31, 2023. The filing details executive compensation and other cor
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX